Mesothelioma is a rare type of cancer, most often caused by exposure to asbestos, according to the U.S. Centers for Disease ...
VT3989 targets TEAD proteins in the Hippo pathway, aiming to inhibit cancer cell growth in mesothelioma. Orphan drug designation offers benefits like tax credits, FDA fee exemptions, and market ...
Malignant peritoneal mesothelioma is a rare and aggressive cancer that develops in the lining around the abdominal organs. Doctors usually treat it with surgery and chemotherapy. Peritoneal ...
Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...
Pleural mesothelioma is an aggressive disease that is enriched for inactivating alterations in tumor suppressor genes. Systemic therapeutic strategies for pleural mesothelioma generally involve ...
AUSTIN, Texas, April 28, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results